B. Salah, A. Zakraoui, H. Zaatour, and A. , A randomized, placebo-controlled trial in Tunisia treating cutaneous leishma ni a sis with par o mo my cin ointment

A. Asilian, T. Jalayer, J. Whitworth, R. Ghasemi, M. Nilforooshzadeh et al., A randomized, placebo-controlled trial of a two-week regimen of aminosidine (par o mo my cin) ointment for treatment of cutaneous leish ma ni a sis in Iran, Am J Trop Med Hyg, vol.53, pp.648-51, 1995.

C. Bern, J. Maguire, and J. Alvar, Complexities of Assessing the Disease Burden Attributable to Leishmaniasis, PLoS Neglected Tropical Diseases, vol.4, issue.10, p.313, 2008.
DOI : 10.1371/journal.pntd.0000313.t001

U. González, M. Pinart, M. Rengifo-pardo, A. Macaya, J. Alvar et al., Interventions for American cutaneous and mucocutaneous leish ma ni a sis, Cochrane Database Syst Rev, vol.2, p.4834, 2009.

D. Kim, H. Chung, J. Bleys, and R. Ghohestani, Is Paromomycin an Effective and Safe Treatment against Cutaneous Leishmaniasis? A Meta-Analysis of 14 Randomized Controlled Trials, PLoS Neglected Tropical Diseases, vol.14, issue.2, p.381, 2009.
DOI : 10.1371/journal.pntd.0000381.s002

U. González, M. Pinart, L. Reveiz, and J. Alvar, Interventions for Old World cutaneous leish ma ni a sis, Cochrane Database Syst Rev, vol.4, p.5067, 2008.

U. González, M. Pinart, and L. Reveiz, Designing and Reporting Clinical Trials on Treatments for Cutaneous Leishmaniasis, Clinical Infectious Diseases, vol.51, issue.4, pp.409-428, 2010.
DOI : 10.1086/655134

P. Buffet, É. Rosenthal, and J. Gangneux, Traitement des leishmanioses en France??: proposition d???un r??f??rentiel consensuel, La Presse M??dicale, vol.40, issue.2, pp.173-84, 2011.
DOI : 10.1016/j.lpm.2010.09.023

F. Modabber, P. Buffet, E. Torreele, G. Milon, S. Croft et al., Consultative meeting to develop a strategy for treatment of cutaneous leish ma ni a sis: Institute Pasteur The sensitivity of Leishmania species to aminosidine, Kinetoplastid Biol Dis J Antimicrob Chemother, vol.635, pp.3-12577, 1995.

K. Seifert, S. Croft, T. Kanyok, A. Killian, K. Rodvold et al., In vitro and in vivo interactions between miltefosine and other antileishmanial drugs Pharmacokinetics of intramuscularly administered aminosidine in healthy subjects, Antimicrob Agents Chemother Antimicrob Agents Chemother, vol.5041, issue.14, pp.73-9982, 1997.

S. Sundar, T. Jha, C. Thakur, P. Sinha, S. Bhattacharya et al., Injectable par o momy cin for visceral leish ma ni a sis in India Aminosidine (par o mo my cin) versus sodium stibogluconate for the treatment of American cutaneous leish ma ni a sis, N Engl J Med Trans R Soc Trop Med Hyg, vol.35688, issue.16, pp.2571-81700, 1994.

J. Soto, M. Grogl, J. Berman, P. Olliaro, A. Llanos-cuentas et al., Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leish ma ni a sis Parenteral aminosidine is not effective for Peruvian mucocutaneous leishma ni a sis, Trans R Soc Trop Med Hyg Am J Trop Med Hyg, vol.8876, issue.18, pp.695-703, 1994.

T. Garnier and S. Croft, Topical treatment for cutaneous leish ma ni a sis, Curr Opin Investig Drugs, vol.3, pp.538-582, 2002.

J. El-on, G. Jacobs, E. Witztum, and C. Greenblatt, Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals., Antimicrobial Agents and Chemotherapy, vol.26, issue.5, pp.745-51, 1984.
DOI : 10.1128/AAC.26.5.745

J. El-on, R. Livshin, Z. Even-paz, D. Hamburger, L. Weinrauch et al., Topical treatment of cutaneous leish ma ni a sis Randomized, controlled, double-blind trial of topical treatment of cutaneous leish ma ni a sis with par o mo my cin plus methylbenzethonium chloride ointment in Guatemala A double-blind clinical trial of the treatment of cutaneous leish ma ni a sis with par o mo my cin ointment Treatment of 'Old World' cutaneous leishma ni a sis with aminosidine ointment: results of an open study in London, The leish maniases in biology and medicine, pp.284-292, 1986.

M. Grogl, B. Schuster, W. Ellis, J. Berman, H. Daneshvar et al., Successful topical treatment of murine cutaneous leish ma ni a sis with a combination of par o mo my cin (aminosidine ) and gentamicin Leishmania mexicana and Leishmania major: attenuation of wildtype parasites and vaccination with attenuated lines Leishmania major H-line attenuated under pressure of gentamicin, induces a Th1 response which protects susceptible BALB/c mice against infection with virulent L. major, J Parasitol J Infect Dis Parasitology, vol.85187, issue.136, pp.354-363, 1999.

B. Salah, A. Buffet, P. Morizot, and G. , 396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leish ma ni asis: a phase 2, randomized, double blind, placebo controlled study, PLoS Negl Trop Dis, vol.2793, issue.5, p.432, 2009.